Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma

The global burden of hepatocellular carcinoma (HCC), one of the frequent causes of cancer-related deaths worldwide, is rapidly increasing partly due to the limited treatment options available for this disease and recurrence due to therapy resistance. Immune checkpoint inhibitors that are proved to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrestha, Ritu, Prithviraj, Prashanth, Anaka, Matthew, Bridle, Kim R., Crawford, Darrell H. G., Dhungel, Bijay, Steel, Jason C., Jayachandran, Aparna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053505/
https://www.ncbi.nlm.nih.gov/pubmed/30057891
http://dx.doi.org/10.3389/fonc.2018.00269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053505/
https://www.ncbi.nlm.nih.gov/pubmed/30057891
http://dx.doi.org/10.3389/fonc.2018.00269

Ejemplares similares